scholarly journals Abbreviated Breast MRI Protocol

2020 ◽  
Author(s):  
Keyword(s):  
Breast Mri ◽  
Mri Protocol ◽  
Abbreviated Breast Mri

Evaluation of a known breast cancer using an abbreviated breast MRI protocol: Correlation of imaging characteristics and pathology with lesion detection and conspicuity

2016 ◽  
Vol 85 (4) ◽  
pp. 815-823 ◽  
Author(s):  
Laura Heacock ◽  
Amy N. Melsaether ◽  
Samantha L. Heller ◽  
Yiming Gao ◽  
Kristine M. Pysarenko ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Mri ◽  
Lesion Detection ◽  
Imaging Characteristics ◽  
Mri Protocol ◽  
Abbreviated Breast Mri

Pearls and Pitfalls of Contrast-Enhanced Mammography

2019 ◽  
Vol 1 (1) ◽  
pp. 64-72 ◽  
Author(s):  
Jordana Phillips ◽  
Valerie J Fein-Zachary ◽  
Priscilla J Slanetz
Keyword(s):  
Imaging Modality ◽  
Breast Mri ◽  
Successful Implementation ◽  
Newly Diagnosed ◽  
Disease Extent ◽  
Diagnostic Problem Solving ◽  
Contrast Enhanced ◽  
Comparable Performance ◽  
Mri Protocol ◽  
Monitoring Response

Abstract Contrast-enhanced mammography (CEM) is a promising new imaging modality that uses a dual-energy acquisition to provide both morphologic and vascular assessment of breast lesions. Although no official BI-RADS lexicon exists, interpretation entails using the mammographic BI-RADS lexicon in combination with that for breast MRI. CEM has comparable performance to breast MRI, with sensitivity of 93–100% and specificity of 80–94%. Currently FDA approved for diagnostic imaging, this technology can be helpful in determining disease extent in patients with newly diagnosed breast malignancy, monitoring response to neoadjuvant therapy, identifying mammographically occult malignancies, and diagnostic problem-solving. Studies are ongoing about its role in screening, especially in women with dense breasts or at elevated risk. There are some challenges to successful implementation into practice, but overall, patients tolerate the study well, and exam times are less than the full breast MRI protocol.

scholarly journals Abbreviated Breast MRI for Screening High-Risk Women: Comparison with the Full Clinical Protocol

2020 ◽  
Author(s):  
Kendrah V Osei ◽  
Anita K Mehta ◽  
Denise M Thigpen ◽  
Jocelyn Rapelyea ◽  
Steven Friedman ◽  
...  
Keyword(s):  
High Risk ◽  
Cancer Detection ◽  
Breast Mri ◽  
Recall Rate ◽  
Report Generation ◽  
High Risk Women ◽  
Patient Recall ◽  
Abbreviated Breast Mri ◽  
Student’S T ◽  
Mri Study

Abstract Objective To compare cancer detection rate (CDR), patient recall, and interpretation time of a full protocol MRI (fpMRI) to an abbreviated MRI protocol (abMRI) in high-risk women. Methods This retrospective study was approved by the IRB. All sequential high-risk screening MRI examinations performed between January 1, 2013, and December 31, 2016, were included. Breast radiologists reviewed patient history, prior images, and abMRI images and recorded their interpretation. Time for interpretation reflected review of the MRI study but not dictation or report generation. Following a minimum 30-day washout period, radiologists interpreted the fpMRI, with interpretation and timing recorded. Data collected included CDR, interpretation time, and patient recall rate. Statistical analyses utilized were Cohen’s kappa coefficient, Student’s t-test, and McNemar’s test. Results Included were 334 MRI examinations of 286 women. Interpretation time was 60.7 seconds for the abMRI compared to 99.4 seconds for the fpMRI, with an average difference of 38.7 ± 5.4 seconds per patient (P < 0.0001). Recall rates were comparable: the abMRI recall rate was 82/334 (24.6%) and the fpMRI 81/334 (24.3%). All five cancers included were detected by both protocols with equal recall rate. However, there were more recommendations for biopsy with the fpMRI, although this difference was not statistically significant. Conclusion The abMRI demonstrated comparable CDR to fpMRI, with shortened interpretation time and similar recall rates. Implementing an abMRI to screen high-risk women reduces imaging and interpretation time, thereby improving cost-effectiveness and the patient experience without reduction in cancer detection.

scholarly journals Correction to: Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery

2017 ◽  
Vol 167 (2) ◽  
pp. 503-503
Author(s):  
Bo Hwa Choi ◽  
Nami Choi ◽  
Mi Young Kim ◽  
Jung-Hyun Yang ◽  
Young Bum Yoo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Mri ◽  
Cancer Surgery ◽  
Breast Cancer Surgery ◽  
History Of ◽  
Abbreviated Breast Mri

scholarly journals The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening: a systematic review and meta-analysis

2021 ◽  
Vol 76 (2) ◽  
pp. 154.e11-154.e22 ◽  
Author(s):  
R. Geach ◽  
L.I. Jones ◽  
S.A. Harding ◽  
A. Marshall ◽  
S. Taylor-Phillips ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Meta Analysis ◽  
Breast Mri ◽  
Potential Utility ◽  
Fast Mri ◽  
Abbreviated Breast Mri

Abbreviated Breast MRI for Estimating Extent of Disease in Newly Diagnosed Breast Cancer

2019 ◽  
Vol 2 (1) ◽  
pp. 43-49 ◽  
Author(s):  
Stephanie Lee-Felker ◽  
Melissa Joines ◽  
Lindsey Storer ◽  
Bo Li ◽  
Nanette DeBruhl ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Predictive Value ◽  
Maximum Intensity Projection ◽  
Breast Mri ◽  
Newly Diagnosed ◽  
Institutional Review ◽  
Abbreviated Breast Mri ◽  
Magnetic Resonance Imaging Mri ◽  
Extent Of Disease ◽  
Mean Sensitivity

Abstract Objective To evaluate extent of disease estimation of abbreviated protocol (ap) magnetic resonance imaging (MRI) compared with full protocol (fp) MRI in newly diagnosed breast cancer. Methods In this institutional review board–approved, Health Insurance Portability and Accountability Act–compliant, retrospective study of women with breast cancer who underwent pretreatment fpMRI on a 3 Tesla MRI in 2013, axial fat-saturated pre- and first postcontrast T1, maximum-intensity projection, and subtraction sequences were interpreted independently by three breast radiologists in two sessions, without and with prior imaging, respectively. Agreement was calculated using Cohen’s kappa. Interpretations were compared with histology or clinical stability. Diagnostic performances were compared using Bennett’s statistic. P < 0.05 was significant. Results Eighty-one women (mean age 56 years, range 32–92 years), 116 lesions, and 95 cancers (mean size 27 mm, range 4–110 mm) were included. Agreement among radiologists for lesion assessment was excellent (0.83). apMRI cancer detection improved with prior imaging (mean sensitivity from 95% to 99%, specificity from 91% to 97%, positive predictive value [PPV] from 92% to 98%, and negative predictive value [NPV] from 95% to 99%) versus fpMRI (sensitivity 98% [93/95], specificity 94% [76/81], PPV 95% [93/98], and NPV 97% [76/78]). apMRI detected all multifocal, multicentric, and contralateral disease seen in 19% (15/81) of women to the same extent as fpMRI. apMRI axillary metastases detection improved with prior imaging (mean sensitivity from 78% to 86%, specificity from 90% to 92%, PPV from 76% to 82%, and NPV from 89% to 94%) versus fpMRI (sensitivity 71% [17/24], specificity 88% [51/58]), PPV 71% [17/24], and NPV 88% [51/58]). Conclusion apMRI may be acceptable for women with newly diagnosed cancer.

Sign in / Sign up

Export Citation Format

Share Document